The director of medical affairs for Molina Healthcare of Florida calls on community and not-for-profit organizations to help the health plan’s Medicaid beneficiaries.
Inhaltsverzeichnis
Anzeigen
Insurers Relax Rules, Help Members After Hurricanes Harvey, Irma
Deadlines were loosened and out-of-network fees, waived. Insurers, like providers, have preparedness plans, but some see a need for closer coordination with other stakeholders.
Jailbreak: How To Ease the Life Sentence of Inflammatory Bowel Disease
Some 1.6 million Americans suffer from life-disrupting IBD. New delivery models that integrate care and engage patients offer some hope.
Young Man Battles For His Life Against Rare Autoimmune Disease
The author’s nephew suffers from a rare form of familial hemophagocytic lymphohistiocytosis. His organs shut down and he’s placed in a medically induced coma. Meanwhile, costs mount to $4.9 million, most of it paid by an employer-sponsored health plan.
Congress Puts ‘Shadow’ Pricing of MS Drugs in the Spotlight
Prices of older drugs go up when new treatments are introduced. The difference between list and net price is also getting some fresh scrutiny.
Time To Lift the Curtain On PBM Wheeling and Dealing
They say their deals need to be kept private so they can drive a hard bargain with manufacturers. But employers, consumer groups, and legislators are calling for more PBM transparency.
TRENDING
NEWSLETTERS
IN THIS ISSUE
MANAGING EDITOR’S MEMO
LEGISLATION & REGULATION
The House has passed legislation that the AMA and others endorse. But the sense that there is a malpractice crisis has ebbed and Senate action is unlikely.
MEDICATION MANAGEMENT
Varying treatment strategies for a highly variable disease have given the new drug an opening—and, besides, it does OK when it comes to QALYs.
TOMORROW’S MEDICINE
FDA approval of the CAR T-cell therapy for leukemia could usher in an era of genetically engineered, individually tailored immunotherapies. But tap those brakes. Long-term results are in short supply—and there’s that $475,000 price tag.
NEWS & COMMENTARY
NEWS & COMMENTARY
NEWS & COMMENTARY
Paul Lendner ist ein praktizierender Experte im Bereich Gesundheit, Medizin und Fitness. Er schreibt bereits seit über 5 Jahren für das Managed Care Mag. Mit seinen Artikeln, die einen einzigartigen Expertenstatus nachweisen, liefert er unseren Lesern nicht nur Mehrwert, sondern auch Hilfestellung bei ihren Problemen.